Clinical Trials Logo

Chronic Back Pain clinical trials

View clinical trials related to Chronic Back Pain.

Filter by:

NCT ID: NCT03312010 Active, not recruiting - Chronic Back Pain Clinical Trials

Tsunami DRG High Frequency Stimulation Study

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Prospective, double blinded, randomized, clinical study investigating the effects of high frequency SCS over exiting nerve roots at T9 for the treatment of chronic back or back and leg pain.

NCT ID: NCT02375633 Completed - Chronic Back Pain Clinical Trials

Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients

Start date: April 2014
Phase: Phase 3
Study type: Interventional

A Multicenter, Randomized, Double-blinded, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients.

NCT ID: NCT01944150 Completed - Tendinopathy Clinical Trials

Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis

HYPTENS
Start date: September 2013
Phase: N/A
Study type: Interventional

At Saint-Antoine's hospital, in CETD a multidisciplinary team takes care of patients with chronic pain. Free-drug techniques are available to reduce their consumption of analgesics. This study is to assess the relief obtained by the simultaneous combination of these two techniques: transcutaneous electrical nerve stimulation and hypnosis.

NCT ID: NCT01766973 Completed - Chronic Back Pain Clinical Trials

Decoding Chronic Pain With fMRI

Start date: April 6, 2013
Phase:
Study type: Observational

Recent evidence suggests that chronic pain is associated with abnormal connectivity between brain regions associated with the processing of pain. We aim to test the diagnostic power of resting state functional magnetic resonance imaging (MRI) to diagnose patients with chronic back pain. Using new methods of image acquisition and analysis we aim to develop a computational method to correctly classify patients and matched control subjects.

NCT ID: NCT01631513 Withdrawn - Pain Clinical Trials

An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)

Start date: August 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate tapentadol Extended Release (ER) in the treatment of moderate to severe chronic pain in participants with a diagnosis of chronic low back pain (LBP) or osteoarthritis (OA) of the hip or knee after conversion from hydrocodone, oxycodone Controlled Release (CR), and/or morphine Sustained Release (SR).